Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica

Ann Neurol. 2012 Mar;71(3):287-8. doi: 10.1002/ana.23538.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Antibodies, Monoclonal / metabolism*
  • Antibodies, Monoclonal / therapeutic use*
  • Aquaporin 4 / antagonists & inhibitors*
  • Aquaporin 4 / metabolism*
  • Humans
  • Neuromyelitis Optica / drug therapy*
  • Neuromyelitis Optica / metabolism*

Substances

  • AQP4 protein, human
  • Antibodies, Monoclonal
  • Aqp4 protein, mouse
  • Aquaporin 4